y (aHR 0.73; 95% CI 0.56–0.94) and oral olanzapine (aHR 0.84; 95% CI 0.73–0.97) were associated with decreased risk, whereas risperidone LAI (aHR 0.54; 95% CI 0.26–1.12), oral aripiprazole (aHR 0.86; 95% CI 0.59–1.24), quetiapine (aHR 0.96; 95% CI 0.78–1.19) and FG-LAIs (aHR 1.25; 95% CI 0.86–1.80) did not reach statistical significance ( Fig. 2 ).
← all excerpts
Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.
1
—
—